Replay available

BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call

BillionToOne, Inc. (NASDAQ: BLLN) Q3 2025 earnings conference call, held 2025-12-09. Replay captured from the company's public earnings webcast.

Tue, December 9, 2025 at 4:30 PMendedReplay
BillionToOne, Inc. (BLLN) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

David Deichler

Investor Relations

Ozan Atay

Co-Founder & Chief Executive Officer

Ross Taylor

Chief Financial Officer

Mark Massaro

Analyst, VTIG

Andrew Brackman

Analyst, William Blair

David Wissenberg

Analyst, Piper Sandler

Casey Woodring

Analyst, J.P. Morgan

Brandon Couillard

Analyst, Wells Fargo

Tycho Peterson

Analyst, Jefferies

Replay transcript excerpt

the billion to one third quarter 2025 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, we'll open up for questions. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one one again. Please be advised that today's call is being recorded. I would like to hand the call over to your speaker today, David Deichler, Investor Relations. Please go ahead Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from Billion to One, we have Ozan Atay, co-founder and chief executive officer, and Ross Taylor, chief financial officer. Earlier today, Billion to One released financial results for the third quarter ended September 30th, 2025. A copy of the press release is available on the company's website. Before we begin, I want to remind you that during this call, we may make forward-looking statements within the meaning of federal securities laws. Such statements about future events may include statements about our financial outlook and performance, market size, products and services, reimbursement coverage, future clinical performance, and other statements. We caution you that such statements reflect our current best judgments and actual results may differ materially from those expressed or implied in any forward-looking statements. Risk factors that may cause our results to differ are discussed in our filings with the FDC, in our previously filed registration statement on Form S-1, our quarterly report on Form 10-Q to be filed following this call, and the current report on Form 8K filed today. Any forward-looking statemen...

More from Billiontoone, Inc.